Filter Publications

Search Results:

Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer

Aust et al., 2017

Scientific Reports

AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer

Priolo et al., 2014

Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study

Stepien et al., 2016

Attenuation of Postoperative Acute Liver Failure by Mesenchymal Stem Cell Treatment Due to Metabolic Implications

Tautenhahn et al., 2015

BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism

Wang et al., 2015

Biomarker candidates for the detection of an infectious etiology of febrile neutropenia

Richter et al., 2015

Combined Proteome and Eicosanoid Profiling Approach for Revealing Implications of Human Fibroblasts in Chronic Inflammation

Tahir et al., 2017

Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance

Lee et al., 2017

Oncology Letters

Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo

Brunelli et al., 2016

Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients

Fontana et al., 2016

Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.

Caiola et al., 2016

Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder

Piyarathna et al., 2017

European Urology Focus

Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway

Panneerselvam et al., 2016

Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.

Schnackenberg et al., 2016

Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested casecontrol study

Fedirko et al., 2017

BMC Medicine

From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer

Bathe et al., 2014

Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells

Belcheva et al., 2014

Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study

Kühn et al., 2016

Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation

Bakiri et al., 2017

Journal of Experimental Medicine

Mass Spectrometry-Based Quantitative Metabolomics Revealed a Distinct Lipid Profile in Breast Cancer Patients

Qiu et al., 2013

Int J Mol Sci 2013, 14 (4), 8047–8061.

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia

Giskeødegård et al., 2015

Metabolic pathways promoting cancer cell survival and growth

Boroughs et al., 2016

Metabolic Phenotyping Reveals a Lipid Mediator Response to Ionizing Radiation

Laiakis et al., 2014

Metabolic signature predicts progression and response after taxane-anthracycline neoadjuvant regimen

Dale et al., 2015

Metabolomic profile in pancreatic cancer patients: a consensusbased approach to identify highly discriminating metabolites

Di Gangi et al., 2015

Metabolomics biomarkers of frailty in elderly breast cancer patients

Corona et al., 2014

Metabolomics for Biomarker Discovery in Gastroenterological Cancer

Nishiumi et al., 2014

Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma

Muqaku et al., 2016

New circulating lipid markers related to breast cancer

Dale et al., 2015

Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Miolo et al., 2016

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation.

Ang et al., 2016

Pre-diagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: A nested case-control study

Fedirko et al., 2014

Review of mass spectrometry-based metabolomics in cancer research

Liesenfeld et al., 2013

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients

Wu et al., Scientific Reports 2017

Scientific Reports

The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life.

Winkels et al., 2014

The Histone Demethylase KDM5 Activates Gene Expression by Recognizing Chromatin Context through Its PHD Reader Motif

Liu and Secombe, 2015

Total items found: 36